Buffington Mohr Mc Neal Becton Dickinson & CO Transaction History

Buffington Mohr Mc Neal

$605 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	SELL	$232.72 - $256.47 $1.41 Million - $1.56 Million	-6,078 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$232.65 - $254.58 $81,427 - $89,103	-350 Reduced 5.44%	6,078 $1.48 Million
Q1 2021 Apr 14, 2021	BUY	$232.09 - $256.88 $5,802 - $6,422	25 Added 0.39%	6,428 $1.56 Million
Q4 2020 Jan 20, 2021	BUY	$221.92 - $245.94 $99,864 - $110,673	450 Added 7.56%	6,403 $1.6 Million
Q3 2020 Oct 26, 2020	SELL	$215.77 - $276.76 $3.88 Million - $4.98 Million	-17,999 Reduced 75.15%	5,953 $1.39 Million
Q2 2020 Jul 27, 2020	SELL	$219.9 - $263.41 $25,508 - $30,555	-116 Reduced 0.48%	23,952 $5.73 Million
Q1 2020 Apr 08, 2020	BUY	$195.69 - $279.01 $163,988 - $233,810	838 Added 3.61%	24,068 $5.53 Million
Q4 2019 Jan 30, 2020	SELL	$236.45 - $266.82 $79,210 - $89,384	-335 Reduced 1.42%	23,230 $6.32 Million
Q3 2019 Oct 10, 2019	BUY	$230.58 - $256.08 $173,396 - $192,572	752 Added 3.3%	23,565 $5.96 Million
Q2 2019 Jul 31, 2019	BUY	$217.4 - $246.08 $155,006 - $175,455	713 Added 3.23%	22,813 $5.75 Million
Q1 2019 Apr 29, 2019	BUY	$206.05 - $248.17 $295,681 - $356,123	1,435 Added 6.94%	22,100 $5.52 Million
Q4 2018 Feb 07, 2019	BUY	$204.73 - $257.93 $613,780 - $773,274	2,998 Added 16.97%	20,665 $4.66 Million
Q3 2018 Oct 25, 2018	BUY	$233.07 - $256.0 $1.87 Million - $2.05 Million	8,014 Added 83.02%	17,667 $4.61 Million
Q2 2018 Jul 30, 2018	SELL	$208.1 - $233.85 $16,648 - $18,708	-80 Reduced 0.82%	9,653 $2.31 Million
Q1 2018 Apr 26, 2018	BUY	$205.46 - $240.27 $2 Million - $2.34 Million	9,733 New	9,733 $2.11 Million

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

News

Stay updated on Buffington Mohr Mc Neal with notifications on news.

Account